Investors & News

Home  >  Investors & News  >  News Releases  >  Press Release Details

Press Release Details

View all news

Clovis Oncology to Present at the Bank of America Merrill Lynch 2013 Health Care Conference in Las Vegas

May 08, 2013

BOULDER, Colo.--(BUSINESS WIRE)--May. 8, 2013-- Clovis Oncology, Inc. (Nasdaq: CLVS) today announced that Erle T. Mast, the Company’s Chief Financial Officer and Executive Vice President, will present at the Bank of America Merrill Lynch 2013 Health Care Conference on Wednesday, May 15, 2013, at 10:40 AM PDT. The conference will be held at the Encore at the Wynn in Las Vegas.

A live webcast of the presentation can be accessed through the investor relations section of the Company’s website at www.clovisoncology.com. Following the live presentation, a replay of the webcast will be available on the Company’s website for 30 days.

About Clovis Oncology

Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets. Clovis Oncology targets development programs at specific subsets of cancer populations, and simultaneously develops diagnostic tools that direct a compound in development to the population that is most likely to benefit from its use. Clovis Oncology is headquartered in Boulder, Colorado, and has additional offices in San Francisco, California and Cambridge, UK.

Source: Clovis Oncology

Clovis Oncology
Anna Sussman, 303-625-5022
asussman@clovisoncology.com
or
Breanna Burkart, 303-625-5023
bburkart@clovisoncology.com

Categories: Press Releases
View all news